Peter Hecht
Fortune : 3 M $ au 31/05/2026
Fortune : 3 M $ au 31/05/2026
Peter M.
Hecht was the founder of Ironwood Pharmaceuticals, Inc., founded in 1998, where he served as Chief Executive Officer & Director from 1998 to 2019.
Dr. Hecht is the founder of Cyclerion Therapeutics, Inc., founded in 2019, where he serves as Director since 2023.
Dr. Hecht is currently Chief Executive Officer & Director at Tisento Therapeutics, Inc. since 2023.
Dr. Hecht is currently Director at Kallyope, Inc. since 2020.
Dr. Hecht is currently Director at Mythic Therapeutics, Inc. Dr. Hecht was Director at Microbia, Inc. Dr. Hecht was Director at Whitehead Institute for Biomedical Research.
Dr. Hecht completed undergraduate and graduate degrees at Stanford University.
Dr. Hecht earned a doctorate from the University of California, Berkeley.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CYCLERION THERAPEUTICS,INC. 12,91 % | 30/03/2026 | 559 203 ( 12,91 % ) | 2 M $ | 31/05/2026 |
| 30/03/2026 | 351 037 ( 100 % ) | 1 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/04/2019 |
Kallyope, Inc.
Kallyope, Inc. BiotechnologyHealth Technology Engages in discovering and developing of novel, neurological and metabolic therapeutics | Directeur/Membre du Conseil | 20/02/2020 |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops cancer therapeutics | Directeur/Membre du Conseil | - |
Tisento Therapeutics, Inc.
Tisento Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treat diseases | Directeur Général | 01/07/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Fondateur | 01/04/2019 |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Directeur/Membre du Conseil | - |
Microbia, Inc.
Microbia, Inc. Pharmaceuticals: MajorHealth Technology Develops microbial manufacturing technologies | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Microbia, Inc.
Microbia, Inc. Pharmaceuticals: MajorHealth Technology Develops microbial manufacturing technologies | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Commercial Services |
Kallyope, Inc.
Kallyope, Inc. BiotechnologyHealth Technology Engages in discovering and developing of novel, neurological and metabolic therapeutics | Health Technology |
Cyclerion Therapeutics, Inc.
Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops cancer therapeutics | Health Technology |
Tisento Therapeutics, Inc.
Tisento Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treat diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national